The order is carried out as a part of the project titled:
– ARG: „PRE-CLINICAL AND CLINICAL DEVELOPMENT OF ARGINASE INHBITOR FOR CANCER IMMUNOTHERAPY” (POIR.01.01.01-00-415/17)
co-financed by the European Union Funds and carried out on the basis of the competitiveness principle
We hereby look for Contractor ready to perform:
Advisory services and expert advice in the field of CMC while carrying out formulation development and GMP quality IMP production for the clinical trial in the OATD-02 research program.